Outset Medical, Inc. (OM)
Market Cap | 194.99M |
Revenue (ttm) | 125.08M |
Net Income (ttm) | -168.77M |
Shares Out | 51.72M |
EPS (ttm) | -3.37 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,174,266 |
Open | 3.680 |
Previous Close | 3.690 |
Day's Range | 3.630 - 3.885 |
52-Week Range | 1.920 - 20.960 |
Beta | 1.99 |
Analysts | Buy |
Price Target | 5.30 (+40.58%) |
Earnings Date | Jul 31, 2024 |
About OM
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal... [Read more]
Financial Performance
In 2023, Outset Medical's revenue was $130.38 million, an increase of 13.00% compared to the previous year's $115.38 million. Losses were -$172.80 million, 6.04% more than in 2022.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for OM stock is "Buy." The 12-month stock price forecast is $5.3, which is an increase of 40.58% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/w/t/conf3-2460022.jpg)
Outset Medical to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/1/m/press12-2421696.jpg)
Outset Medical Reports First Quarter 2024 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexi...
![](https://cdn.snapi.dev/images/v1/d/l/press11-2411786.jpg)
Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, a...
![](https://cdn.snapi.dev/images/v1/l/4/conf7-2404458.jpg)
Outset Medical to Present at Upcoming Investor Conferences
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/q/q/conf6-2380512.jpg)
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/7/1/press3-2375776.jpg)
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, a...
![](https://cdn.snapi.dev/images/v1/3/0/press9-2371377.jpg)
Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/y/z/image31-2330784.jpeg)
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March - Inspire Veterinary (NASDAQ:IVP), Fractyl Health (NASDAQ:GUTS)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
![](https://cdn.snapi.dev/images/v1/s/r/press20-2323056.jpg)
Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/v/m/conf10-2293473.jpg)
Outset Medical to Present at the 44th Annual TD Cowen Health Care Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/d/x/press8-2287045.jpg)
Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexi...
![](https://cdn.snapi.dev/images/v1/v/8/conf9-2259779.jpg)
Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/j/p/press6-2220189.jpg)
Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/h/t/conf2-2214659.jpg)
Outset Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/4/j/conf18-2176713.jpg)
Outset Medical to Present at BofA Home Care Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/4/5/press1-2145293.jpg)
Outset Medical Reports Third Quarter 2023 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexi...
![](https://cdn.snapi.dev/images/v1/g/p/press17-2140145.jpg)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
NEW YORK , Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset" or the "Company") (NASDAQ: OM). Such investors are advised to con...
![](https://cdn.snapi.dev/images/v1/h/5/press7-2133049.jpg)
New Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo® Hemodialysis System on Equitable Kidney Care
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis with its Tablo® Hemodialysis System, today an...
![](https://cdn.snapi.dev/images/v1/3/r/conf7-2128972.jpg)
Outset Medical to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, t...
![](https://cdn.snapi.dev/images/v1/r/h/press7-2103072.jpg)
Berman Tabacco Announces Investigation of Outset Medical Inc. (OM) for Potential Securities Law Violations
BOSTON--(BUSINESS WIRE)---- $CS #classaction--Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Outset Medical Inc. ("Outset" or the "...
![](https://cdn.snapi.dev/images/v1/i/d/press10-2101610.jpg)
Outset Medical Reports Preliminary Third Quarter 2023 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), today announced preliminary financial results for the third quarter ended Sept. 30, 2023, and provided...
![](https://cdn.snapi.dev/images/v1/k/y/press7-2101041.jpg)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of Investors
LOS ANGELES , Oct. 12, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, continues its investigation on behalf of Outset Medical, Inc. ("Outset ...
![](https://cdn.snapi.dev/images/v1/3/a/press12-2100031.jpg)
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of Investors
BENSALEM, Pa. , Oct. 11, 2023 /PRNewswire/ -- Law Offices of Howard G.
![](https://cdn.snapi.dev/images/v1/w/8/press20-2100016.jpg)
The Law Offices of Frank R. Cruz Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of Investors
LOS ANGELES , Oct. 11, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM) on behalf of investors...
![](https://cdn.snapi.dev/images/v1/z/6/press20-2087775.jpg)
Trace Medical & Outset Medical sign long-term distribution agreement for Tablo® Hemodialysis System
WHITMORE LAKE, Mich.--(BUSINESS WIRE)--Trace Medical, the national leader in advanced respiratory rentals and biomedical services, has announced a long-term distribution agreement with Outset Medical ...